Personalized assessment and management of women at risk for breast cancer in North America

Women's Health
Sandhya PruthiTherese Bevers

Abstract

Many women at increased risk for breast cancer would benefit from referral for genetic testing, enhanced screening, preventive therapy or risk-reducing surgery. We present a visual model and a step-wise approach to assist with a personalized risk stratification and management of these women. We present current recommendations with respect to lifestyle behaviors and mammographic screening, and we review the current evidence regarding enhanced screening and risk-reducing therapies. We discuss the usefulness of three risk-assessment tools in determining whether a woman qualifies for genetic testing, enhanced screening or preventive therapy and present four cases to demonstrate the usefulness of this approach in the clinical setting.

References

Sep 24, 1999·Journal of the National Cancer Institute·J P CostantinoH S Wieand
Nov 5, 1999·Journal of the National Cancer Institute·M H GailV Vogel
Sep 21, 2000·American Journal of Epidemiology·P A van den BrandtD J Hunter
Mar 10, 2001·Journal of the National Cancer Institute·B RockhillG A Colditz
Nov 8, 2001·Journal of the National Cancer Institute·L C HartmannR B Jenkins
Nov 17, 2001·JAMA : the Journal of the American Medical Association·M C KingUNKNOWN National Surgical Adjuvant Breast and Bowel Project
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerUNKNOWN American Society of Clinical Oncology
Sep 11, 2003·JAMA : the Journal of the American Medical Association·Anne McTiernanUNKNOWN Women's Health Initiative Cohort Study
Jan 26, 2006·The American Journal of Surgical Pathology·Fabiola MedeirosChristopher P Crum
Jun 7, 2006·JAMA : the Journal of the American Medical Association·Victor G VogelUNKNOWN National Surgical Adjuvant Breast and Bowel Project (NSABP)
Nov 15, 2006·Archives of Internal Medicine·Eunyoung ChoWalter C Willett
Jan 6, 2007·American Journal of Epidemiology·Shumin M ZhangJulie E Buring
Mar 21, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Cedric F GarlandFrank C Garland
Mar 30, 2007·CA: a Cancer Journal for Clinicians·Debbie SaslowUNKNOWN American Cancer Society Breast Cancer Advisory Group
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining Chen, Giovanni Parmigiani
Nov 29, 2007·Journal of the National Cancer Institute·Mitchell H GailLeslie Bernstein
May 15, 2008·JAMA : the Journal of the American Medical Association·Wendie A BergUNKNOWN ACRIN 6666 Investigators
Nov 5, 2008·CA: a Cancer Journal for Clinicians·Martin C MahoneyWalter C Willett
Jan 15, 2009·Journal of the National Cancer Institute·Timothy R RebbeckSusan M Domchek
Sep 16, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Cecelia A BellcrossLorraine T Meisner
Nov 19, 2009·Annals of Internal Medicine·UNKNOWN US Preventive Services Task Force
Dec 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianSylvia K Plevritis
Apr 21, 2010·Cancer Prevention Research·Victor G VogelUNKNOWN National Surgical Adjuvant Breast and Bowel Project
Apr 20, 2011·Archives of Surgery·Tina W F Yen
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew N FreedmanWorta McCaskill-Stevens
May 13, 2011·Journal of the National Cancer Institute·Rayna K MatsunoMitchell H Gail
Jun 7, 2011·The New England Journal of Medicine·Paul E GossUNKNOWN NCIC CTG MAP.3 Study Investigators
Nov 23, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marcello TonelliUNKNOWN Canadian Task Force on Preventive Health Care
May 17, 2012·British Journal of Cancer·K PassaperumaS A Narod
Nov 28, 2012·Women's Health·Julia A FilesSandhya Pruthi
Jul 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kala VisvanathanScott M Lippman
Dec 25, 2013·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Feb 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy P M FinchSteven A Narod

❮ Previous
Next ❯

Citations

Jul 24, 2015·Annals of Surgical Oncology·Sandhya PruthiTherese B Bevers
Sep 13, 2016·Current Breast Cancer Reports·Susan HumRuth Heisey
Nov 1, 2018·Journal of the American Medical Informatics Association : JAMIA·Zhijun YinBradley A Malin

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy
biopsy
biopsies
hysterectomy

Software Mentioned

Medscape
IBIS
RST

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
William A Hensel
Medicina clínica
Juan Gérvas Camacho, Miguel Angel Ripoll Lozano
© 2021 Meta ULC. All rights reserved